American Century Companies’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-37,445
Closed -$374K 1373
2019
Q2
$374K Buy
37,445
+21,089
+129% +$228K ﹤0.01% 1171
2019
Q1
$211K Buy
+16,356
New +$244K ﹤0.01% 1191
2017
Q3
Sell
-209,192
Closed -$3.85M 1420
2017
Q2
$3.85M Buy
209,192
+6,305
+3% +$125K ﹤0.01% 914
2017
Q1
$4.58M Buy
202,887
+18,858
+10% +$451K ﹤0.01% 900
2016
Q4
$6.4M Buy
+184,029
New +$5.5M 0.01% 789
2015
Q4
Sell
-51,657
Closed -$2.05M 1420
2015
Q3
$2.05M Sell
51,657
-684,540
-93% -$42.5M ﹤0.01% 1013
2015
Q2
$50.8M Buy
736,197
+213,445
+41% +$13.4M 0.06% 382
2015
Q1
$28.6M Buy
+522,752
New +$24.9M 0.03% 475

Other funds holding AMAG

American Century Companies's AMAG Position: Q3 2019 in Review

American Century Companies sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 37,445 shares — an estimated $374K sold.

American Century Companies first reported a position in AMAG in Q1 2015 and held it in 8 quarters. The position peaked at $50.8M in Q2 2015. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

  • American Century Companies reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • American Century Companies sold 37,445 AMAG Pharmaceuticals shares in Q3 2019, an estimated $374K.
  • American Century Companies first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 8 quarters.
  • American Century Companies's AMAG Pharmaceuticals position peaked at $50.8M in Q2 2015.
  • 156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.